Patient Outcomes in Renal-Limited Antineutrophil Cytoplasmic Antibody Vasculitis With Inactive Histology

Jennette, 2013, 2012 revised International Chapel Hill consensus conference nomenclature of vasculitides, Arthritis Rheum, 65, 1, 10.1002/art.37715 Berden, 2010, Histopathologic classification of ANCA-associated glomerulonephritis, J Am Soc Nephrol, 21, 1628, 10.1681/ASN.2010050477 Cordova-Sanchez, 2016, Clinical presentation and outcome prediction of clinical, serological, and histopathological classification schemes in ANCA-associated vasculitis with renal involvement, Clin Rheumatol, 35, 1805, 10.1007/s10067-016-3195-z Neumann, 2005, Histological and clinical predictors of early and late renal outcome in ANCA-associated vasculitis, Nephrol Dial Transplant, 20, 96, 10.1093/ndt/gfh563 Hauer, 2002, Long-term renal injury in ANCA-associated vasculitis: an analysis of 31 patients with follow-up biopsies, Nephrol Dial Transplant, 17, 587, 10.1093/ndt/17.4.587 Hauer, 2002, Determinants of outcome in ANCA-associated glomerulonephritis: a prospective clinico-histopathological analysis of 96 patients, Kidney Int, 62, 1732, 10.1046/j.1523-1755.2002.00605.x Bajema, 1999, Kidney biopsy as a predictor for renal outcome in ANCA-associated necrotizing glomerulonephritis, Kidney Int, 56, 1751, 10.1046/j.1523-1755.1999.00758.x Vergunst, 2003, An index for renal outcome in ANCA-associated glomerulonephritis, Am J Kidney Dis, 41, 532, 10.1053/ajkd.2003.50115 Levey, 1999, A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group, Ann Intern Med, 130, 461, 10.7326/0003-4819-130-6-199903160-00002 de Lind van Wijngaarden, 2006, Clinical and histologic determinants of renal outcome in ANCA-associated vasculitis: a prospective analysis of 100 patients with severe renal involvement, J Am Soc Nephrol, 17, 2264, 10.1681/ASN.2005080870 Lee, 2014, Predictors of treatment outcomes in ANCA-associated vasculitis with severe kidney failure, Clin J Am Soc Nephrol, 9, 905, 10.2215/CJN.08290813 Hogan, 2005, Predictors of relapse and treatment resistance in antineutrophil cytoplasmic antibody-associated small-vessel vasculitis, Ann Intern Med, 143, 621, 10.7326/0003-4819-143-9-200511010-00005 Nachman, 1996, Treatment response and relapse in antineutrophil cytoplasmic autoantibody-associated microscopic polyangiitis and glomerulonephritis, J Am Soc Nephrol, 7, 33, 10.1681/ASN.V7133 Walters, 2015, Interventions for renal vasculitis in adults, Cochrane Database Syst Rev, CD003232 Guillevin, 1997, A prospective, multicenter, randomized trial comparing steroids and pulse cyclophosphamide versus steroids and oral cyclophosphamide in the treatment of generalized Wegener's granulomatosis, Arthritis Rheum, 40, 2187, 10.1002/art.1780401213 Walsh, 2013, Long-term follow-up of patients with severe ANCA-associated vasculitis comparing plasma exchange to intravenous methylprednisolone treatment is unclear, Kidney Int, 84, 397, 10.1038/ki.2013.131 Neumann, 2003, Glomerular immune deposits are associated with increased proteinuria in patients with ANCA-associated crescentic nephritis, Nephrol Dial Transplant, 18, 524, 10.1093/ndt/18.3.524